Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

PharmAbcine to present the final data of Phase IIa rGBM trial at SNO 2020

prnasiaNovember 17, 2020

Tag: SNO 2020 , PharmAbcine , rGBM , olinvacimab

PharmaSources Customer Service